Alkem Laboratories Ltd (ALKEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
47
About the Report
About the Report
Summary
Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The company's products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for acute and chronic diseases such as central nervous system disorders, gastro-intestinal infections, diabetes, malaria, pain, cardiovascular diseases and immune disorders. It offers vitamins, minerals and nutrition products. The company distributes its products through a wide network of distributors all over India. It exports products to Europe, Australia, South-East Asia, North America, South America, Russia-CIS and Africa. Alkem is headquartered in Mumbai, Maharashtra, India.
Alkem Laboratories Ltd (ALKEM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Alkem Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alkem Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Alkem Labs Acquires Formulation Manufacturing Facility from Long Pharma 13
Alkem Labs Acquires Manufacturing Assets from NORAC 14
Partnerships 15
Alkem Labs Enters into Agreement with Haw Par 15
Licensing Agreements 16
Alkem Labs Enters into Licensing Agreement with Stempeutics Research 16
Alkem Enters into Licensing Agreement with MediPost for Cartistem 17
Dong-A Pharma Enters Into Licensing Agreement With Alkem Labs For DA-1229 18
Equity Offering 19
Alkem Labs Raises USD202 Million in IPO 19
Asset Transactions 21
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 21
Acquisition 22
Alkem Labs Acquires 51% Stake in Cachet Pharma 22
Alkem Labs Acquires 51% Stake in Indchemie Health Specialities 23
Alkem Labs Acquires Remaining 20% Stake in Enzene Biosciences 24
Alkem Labs Acquires Remaining 80% Stake in Pharmacor from S&B 25
Alkem Laboratories Ltd-Key Competitors 26
Alkem Laboratories Ltd-Key Employees 27
Alkem Laboratories Ltd-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
May 30, 2018: Alkem reports Q4FY18 and FY18 Results 30
Aug 11, 2017: Alkem Reports Q1FY18 Results 32
Corporate Communications 33
Oct 31, 2017: Alkem Laboratories: Resignation of Chief Executive Officer (CEO) 33
May 17, 2017: Alkem Laboratories Announces resignation of Independent Director 34
Legal and Regulatory 35
Aug 11, 2018: Alkem Laboratories provides update on the US FDA Inspection at Manufacturing Facility at California, USA 35
Aug 10, 2018: Update on US FDA inspection at Alkem's Baddi Facility 36
Jul 24, 2018: Alkem receives EIR from the US FDA for its Daman formulation facility 37
Mar 28, 2018: Alkem Labs: Update on USFDA Inspection at its manufacturing facility at Amaliya in India 38
Jan 10, 2018: Update on US FDA Inspection at Alkem's Baddi Facility 39
Jan 10, 2018: Alkem receives EIR from the US FDA for its Baddi formulation facility 40
Oct 28, 2017: US FDA completes inspection at Alkem Laboratories's St Louis facility 41
Sep 18, 2017: Alkem Announces Update on US FDA Inspection at Alkem's Baddi Facility 42
Jul 14, 2017: Update on US FDA inspection for Bioequivalence Facility at Taloja 43
May 23, 2017: Alkem receives EIR from the US FDA for its Baddi Management Manufacturing Facility 44
Mar 29, 2017: Alkem receives EIR from the US FDA for its Alkem's Ankaleshwar API Facility 45
Mar 10, 2017: Alkem Laboratories Announces Update on US FDA Inspection at Alkem s Baddi Facility 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List of Figure
List of Figures
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alkem Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 11
List of Table
List of Tables
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alkem Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Alkem Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Alkem Labs Acquires Formulation Manufacturing Facility from Long Pharma 13
Alkem Labs Acquires Manufacturing Assets from NORAC 14
Alkem Labs Enters into Agreement with Haw Par 15
Alkem Labs Enters into Licensing Agreement with Stempeutics Research 16
Alkem Enters into Licensing Agreement with MediPost for Cartistem 17
Dong-A Pharma Enters Into Licensing Agreement With Alkem Labs For DA-1229 18
Alkem Labs Raises USD202 Million in IPO 19
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 21
Alkem Labs Acquires 51% Stake in Cachet Pharma 22
Alkem Labs Acquires 51% Stake in Indchemie Health Specialities 23
Alkem Labs Acquires Remaining 20% Stake in Enzene Biosciences 24
Alkem Labs Acquires Remaining 80% Stake in Pharmacor from S&B 25
Alkem Laboratories Ltd, Key Competitors 26
Alkem Laboratories Ltd, Key Employees 27
Alkem Laboratories Ltd, Subsidiaries 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.